BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15727676)

  • 1. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea.
    Chu CY
    Br J Dermatol; 2005 Feb; 152(2):396-9. PubMed ID: 15727676
    [No Abstract]   [Full Text] [Related]  

  • 2. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
    Chu CY
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
    Lee DH; Li K; Suh DH
    Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream.
    Gorman CR; White SW
    Arch Dermatol; 2005 Sep; 141(9):1168. PubMed ID: 16172323
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosacea-like eruption due to topical pimecrolimus.
    El-Heis S; Buckley DA
    Dermatol Online J; 2015 May; 21(5):. PubMed ID: 26295863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pimecrolimus cream 1% for the treatment of papulopustular eruption related to epidermal growth factor receptor inhibitors: a case series and a literature review of therapeutic approaches.
    Nikolaou V; Stratigos A; Antoniou C; Kiagia M; Nikolaou C; Katsambas A; Syrigos K
    Dermatology; 2010; 220(3):243-8. PubMed ID: 20110632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steroid-aggravated rosacea: successful therapy with pimecrolimus].
    Meykadeh N; Meiss F; Marsch WC; Fischer M
    Hautarzt; 2007 Apr; 58(4):338-42. PubMed ID: 16874534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of granulomatous rosacea successfully treated with pimecrolimus cream.
    Gül U; Gönül M; Kiliç A; Koçak O; Aslan E; Ergül G; Kulaçoğlu S
    J Dermatolog Treat; 2008; 19(5):313-5. PubMed ID: 18608739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment.
    Ljubojeviae S; Basta-Juzbasiae A; Lipozenèiae J
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):121-6. PubMed ID: 12046812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiology and therapy of perioral dermatitis].
    Buck A; Kalkoff KW
    Dtsch Med Wochenschr; 1974 Feb; 99(8):366-8. PubMed ID: 4150785
    [No Abstract]   [Full Text] [Related]  

  • 12. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial.
    Firooz A; Solhpour A; Gorouhi F; Daneshpazhooh M; Balighi K; Farsinejad K; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Aug; 142(8):1066-7. PubMed ID: 16924062
    [No Abstract]   [Full Text] [Related]  

  • 13. Pimecrolimus-induced rosacea-like demodicidosis.
    Yoon TY; Kim HJ; Kim MK
    Int J Dermatol; 2007 Oct; 46(10):1103-5. PubMed ID: 17910727
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo.
    Mayoral FA; Vega JM; Stavisky H; McCormick CL; Parneix-Spake A
    J Drugs Dermatol; 2007 May; 6(5):517-21. PubMed ID: 17679186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP; de Arruda EA; Vitoriano MA; de Moraes Filho MO; Bezerra FA; de Magalhães Holanda E; de Moraes ME
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosaceiform eruption to pimecrolimus.
    El Sayed F; Ammoury A; Dhaybi R; Bazex J
    J Am Acad Dermatol; 2006 Mar; 54(3):548-50. PubMed ID: 16488319
    [No Abstract]   [Full Text] [Related]  

  • 18. Which steroids for the treatment of skin disorders on the face?
    Dubertret L
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):121. PubMed ID: 12046811
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rosacea fulminans: report of two cases].
    Sanz-Motilva V; Martorell Calatayud A; Rivera R; Vanaclocha-Sebastián F
    Rev Med Chil; 2012 May; 140(5):637-9. PubMed ID: 23096671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid rosacea: a friendly pharmacist syndrome.
    Fisher AA
    Cutis; 1987 Sep; 40(3):209-11. PubMed ID: 2958240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.